218 related articles for article (PubMed ID: 33095860)
1. CNCDatabase: a database of non-coding cancer drivers.
Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
[TBL] [Abstract][Full Text] [Related]
2. Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.
Liu EM; Martinez-Fundichely A; Diaz BJ; Aronson B; Cuykendall T; MacKay M; Dhingra P; Wong EWP; Chi P; Apostolou E; Sanjana NE; Khurana E
Cell Syst; 2019 May; 8(5):446-455.e8. PubMed ID: 31078526
[TBL] [Abstract][Full Text] [Related]
3. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
[TBL] [Abstract][Full Text] [Related]
4. Cancer regulatory variation.
Hennessey RC; Brown KM
Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
[TBL] [Abstract][Full Text] [Related]
5. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
6. Loss-of-function uORF mutations in human malignancies.
Schulz J; Mah N; Neuenschwander M; Kischka T; Ratei R; Schlag PM; Castaños-Vélez E; Fichtner I; Tunn PU; Denkert C; Klaas O; Berdel WE; von Kries JP; Makalowski W; Andrade-Navarro MA; Leutz A; Wethmar K
Sci Rep; 2018 Feb; 8(1):2395. PubMed ID: 29402903
[TBL] [Abstract][Full Text] [Related]
7. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis of Somatic Mutations in Non-coding Regions Altering RNA Secondary Structures in Cancer Genomes.
He F; Wei R; Zhou Z; Huang L; Wang Y; Tang J; Zou Y; Shi L; Gu X; Davis MJ; Su Z
Sci Rep; 2019 Jun; 9(1):8205. PubMed ID: 31160636
[TBL] [Abstract][Full Text] [Related]
9. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
10. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.
Sherman MA; Yaari AU; Priebe O; Dietlein F; Loh PR; Berger B
Nat Biotechnol; 2022 Nov; 40(11):1634-1643. PubMed ID: 35726091
[TBL] [Abstract][Full Text] [Related]
12. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Rheinbay E; Nielsen MM; Abascal F; Wala JA; Shapira O; Tiao G; Hornshøj H; Hess JM; Juul RI; Lin Z; Feuerbach L; Sabarinathan R; Madsen T; Kim J; Mularoni L; Shuai S; Lanzós A; Herrmann C; Maruvka YE; Shen C; Amin SB; Bandopadhayay P; Bertl J; Boroevich KA; Busanovich J; Carlevaro-Fita J; Chakravarty D; Chan CWY; Craft D; Dhingra P; Diamanti K; Fonseca NA; Gonzalez-Perez A; Guo Q; Hamilton MP; Haradhvala NJ; Hong C; Isaev K; Johnson TA; Juul M; Kahles A; Kahraman A; Kim Y; Komorowski J; Kumar K; Kumar S; Lee D; Lehmann KV; Li Y; Liu EM; Lochovsky L; Park K; Pich O; Roberts ND; Saksena G; Schumacher SE; Sidiropoulos N; Sieverling L; Sinnott-Armstrong N; Stewart C; Tamborero D; Tubio JMC; Umer HM; Uusküla-Reimand L; Wadelius C; Wadi L; Yao X; Zhang CZ; Zhang J; Haber JE; Hobolth A; Imielinski M; Kellis M; Lawrence MS; von Mering C; Nakagawa H; Raphael BJ; Rubin MA; Sander C; Stein LD; Stuart JM; Tsunoda T; Wheeler DA; Johnson R; Reimand J; Gerstein M; Khurana E; Campbell PJ; López-Bigas N; ; ; Weischenfeldt J; Beroukhim R; Martincorena I; Pedersen JS; Getz G;
Nature; 2020 Feb; 578(7793):102-111. PubMed ID: 32025015
[TBL] [Abstract][Full Text] [Related]
13. The Untranslated Regions of mRNAs in Cancer.
Schuster SL; Hsieh AC
Trends Cancer; 2019 Apr; 5(4):245-262. PubMed ID: 30961831
[TBL] [Abstract][Full Text] [Related]
14. Purifying selection acts on coding and non-coding sequences of paralogous genes in Arabidopsis thaliana.
Hoffmann RD; Palmgren M
BMC Genomics; 2016 Jun; 17():456. PubMed ID: 27296049
[TBL] [Abstract][Full Text] [Related]
15. Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW; Furney SJ
Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
[TBL] [Abstract][Full Text] [Related]
16. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements.
Barrett LW; Fletcher S; Wilton SD
Cell Mol Life Sci; 2012 Nov; 69(21):3613-34. PubMed ID: 22538991
[TBL] [Abstract][Full Text] [Related]
17. Pathway and network analysis of more than 2500 whole cancer genomes.
Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
[TBL] [Abstract][Full Text] [Related]
18. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.
Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D
PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488
[TBL] [Abstract][Full Text] [Related]
19. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
